Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of SNN mRNA | decreases expression | 18648102
|
D019386 |
Alendronate |
Alendronate affects the expression of SNN mRNA | affects expression | 16079270
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of SNN mRNA | decreases expression | 16648578
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SNN mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in decreased expression of SNN mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of SNN mRNA | decreases expression | 12075121
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in decreased expression of SNN mRNA | decreases expression | 17553608
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of SNN mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SNN mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SNN mRNA | affects expression | 16079270
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SNN mRNA | decreases expression | 17557909
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased expression of SNN mRNA | increases expression | 15954086
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of SNN mRNA | decreases expression | 12102619
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SNN mRNA | affects binding|decreases expression|increases activity | 19710929
|
D020849 |
Raloxifene |
Raloxifene affects the expression of SNN mRNA | affects expression | 16079270
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of SNN mRNA] | decreases reaction|increases expression | 19225232
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.82 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.04 | 3712494 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
7.04 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.53 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.63 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.17 | 19483382 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.91 | 14991843 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.52 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.32 | 16357521 15144691 18412241 16436596 16651633 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.07 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.07 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.07 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.07 | 17893378 17242785 15758505 16837676 15775269 17049068 15572757 17595753 17440819 17952589 16912660 17261762 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
1.75 | 7296757 3581430 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.23 | 16247446 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.10 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.20 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.45 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.93 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
7.93 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.38 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.38 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
11.38 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.05 | 17160924 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
19.39 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
19.39 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
19.39 | 15861022 17681005 16919318 11677210 17333356 16105132 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
19.39 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.66 | 15800139 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.90 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.89 | 20392896 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.19 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 11906362 11298694 12868966 8970840 2524372 14531868 18759878 8156756 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.62 | 11508273 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.60 | 17308373 15920148 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
9.60 | 11427623 18630688 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
1.97 | 16192314 9328219 7440962 6482804 18289764 11289319 6679447 18648102 18692083 8291058 1440618 9022650 9653073 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.05 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.99 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.99 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.24 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.24 | 15845917 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.11 | 3581430 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.01 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.01 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
19.01 | 17473493 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.29 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
valsartan |
9.29 | 16893502 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.85 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.50 | 16357521 16651633 18412241 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.58 | 16928621 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
5.25 | 11554966 11284996 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.55 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.44 | 20558911 |
MESH:D006333 |
Heart Failure |
|
valsartan |
7.44 | 19027736 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.04 | 19176532 18467677 19772884 16221962 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
4.74 | 16769263 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.88 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.88 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
valsartan |
8.88 | 20102058 10903974 12850387 16475468 18344623 11427623 18390891 12692753 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.47 | 11560862 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.50 | 17937319 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.37 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.37 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.69 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.49 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
6.49 | 16893502 12164870 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.63 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.63 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
12.63 | 17379185 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.53 | 16973256 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.81 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
2.81 | 15504291 16872305 15619341 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.83 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.55 | 1399818 3712494 598648 6587162 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
3.80 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
3.80 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
3.80 | 16019985 6695378 16271038 17703301 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.96 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.09 | 15375218 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.19 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
6.67 | 19196723 15591091 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
6.67 | 10838139 10767621 18041768 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.05 | 17943659 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.76 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
5.16 | 14659530 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.62 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.46 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
6.05 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.05 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.62 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.48 | 3581430 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
5.26 | 16946489 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.26 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.44 | 16707424 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.85 | 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.01 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.93 | 6679447 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.47 | 17160924 16003739 16651423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.45 | 4026338 6482804 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.05 | 17160924 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
7.85 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.85 | 19059307 15775268 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.26 | 15758505 17893378 15579764 17823083 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.07 | 16144296 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.00 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.24 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.45 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.45 | 16536755 16220300 15731164 |
MESH:D011507 |
Proteinuria |
|
valsartan |
4.89 | 18344623 17664856 12164870 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.82 | 17241526 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.62 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.70 | 8532709 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.84 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16045194 16684133 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.21 | 15790496 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.90 | 3712494 1399818 6582329 7505956 6587162 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.27 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.23 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.23 | 17572228 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.27 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.75 | 19027736 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.62 | 16343187 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |